Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Sales | 177,234 | 188,529 | 171,217 | 170,242 | 159,243 |
| Cost of Goods | 61,965 | 64,500 | 60,720 | 55,420 | 49,990 |
| Gross Profit | 115,269 | 124,050 | 110,490 | 114,810 | 109,240 |
| Operating Expenses | 55,215 | 55,280 | 52,880 | 49,870 | 45,290 |
| Operating Income | 61,019 | 69,249 | 58,337 | 65,372 | 64,953 |
| Interest Expense | 2,768 | 2,780 | 2,740 | 2,790 | 2,810 |
| Other Income | 167,871 | 44,161 | -157 | 1,248 | -19,503 |
| Pre-tax Income | 226,122 | 110,630 | 55,440 | 63,830 | 42,640 |
| Income Tax | 83,970 | 37,590 | 18,730 | 17,670 | 19,670 |
| Net Income Continuous | 142,152 | 73,042 | 36,702 | 46,166 | 22,971 |
| Net Income | $130,139 | $73,042 | $36,702 | $46,166 | $22,971 |
| EPS Basic Total Ops | 1.31 | 0.75 | 0.38 | 0.47 | 0.23 |
| EPS Basic Continuous Ops | 1.43 | 0.75 | 0.38 | 0.47 | 0.23 |
| EPS Diluted Total Ops | 1.29 | 0.75 | 0.38 | 0.47 | 0.23 |
| EPS Diluted Continuous Ops | 1.41 | 0.75 | 0.38 | 0.47 | 0.23 |
| EBITDA(a) | $72,742 | $81,519 | $69,527 | $75,952 | $74,913 |